Abbott Laboratories vs. Arcus Biosciences, Inc.
Abbott Laboratories and Arcus Biosciences, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | RCUS | |
|---|---|---|
| Market Cap | $177.28 billion | $3.02 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | RCUS | |
|---|---|---|
| Dividend Yield | 2.51% | — |
ABT and RCUS split the dividend factors evenly.
Risk & Sentiment
| ABT | RCUS | |
|---|---|---|
| Short Interest | 0.57% | 0.06% |
RCUS leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, RCUS overview, RCUS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.